ストックスクリーナーアプリを入手
4.65
3.91%
-0.21
前日終値:
$4.86
開ける：
$4.86
24時間の取引高:
511.06K
Relative Volume:
0.44
時価総額：
$595.21M
収益：
$193.01M
当期純損益:
$-12.15M
株価収益率:
-51.67
EPS:
-0.09
ネットキャッシュフロー:
$454.00K
1週間 パフォーマンス:
-3.91%
1か月 パフォーマンス:
-15.09%
6か月 パフォーマンス:
+45.03%
1年 パフォーマンス:
-24.80%
1日の値動き範囲:
$4.645
$4.905
1週間の範囲:
$4.6719
$5.1642
52週間の値動き範囲:
$2.37
$7.30
Cytek Biosciences Inc Stock (CTKB) Company Profile
名前
Cytek Biosciences Inc
セクター
電話
(877) 922-9835
住所
47215 LAKEVIEW BOULEVARD, FREMONT
CTKB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
4.655 | 621.42M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
128.60 | 218.16B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.05 | 137.24B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
352.77 | 135.41B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
98.81 | 128.03B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.59 | 48.21B | 5.88B | 1.34B | 799.60M | 2.3489 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-02 | 再開されました | Morgan Stanley | Equal-Weight |
| 2025-05-09 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-01-31 | ダウングレード | Goldman | Buy → Sell |
| 2023-12-14 | 開始されました | Stephens | Overweight |
| 2023-07-19 | 開始されました | Raymond James | Mkt Perform |
| 2022-01-06 | 再開されました | Piper Sandler | Overweight |
すべてを表示
Cytek Biosciences Inc (CTKB) 最新ニュース
Cytek BioSciences Inc (CTKB) expanding its growth trajectory ahead - Setenews
Why Cytek Biosciences Inc. (8EQ) stock stays on buy listsQuarterly Portfolio Report & High Accuracy Buy Signal Tips - Newser
Institutional Owners May Consider Drastic Measures as Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Recent US$58m Drop Adds to Long-term Losses - 富途牛牛
Brown Capital Management LLC Has $24.17 Million Stock Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
Is Cytek Biosciences Inc. stock overvalued by current metricsJuly 2025 EndofMonth & Precise Entry and Exit Recommendations - Newser
Can Cytek Biosciences Inc. stock beat market expectations this quarter - Newser
Can Cytek Biosciences Inc. (8EQ) stock sustain revenue momentumGDP Growth & Safe Capital Growth Plans - Newser
Why Cytek Biosciences Inc. stock attracts global investorsWeekly Trend Report & Fast Gain Stock Tips - Newser
Can Cytek Biosciences Inc. stock maintain operating marginsEarnings Growth Summary & Entry Point Strategy Guides - Newser
Is Cytek Biosciences Inc. (8EQ) stock attractive for dividend growthJuly 2025 Sentiment & Community Verified Trade Alerts - Newser
What is Cytek BioSciences Inc (CTKB) Stock Return on Shareholders’ Capital? - setenews.com
Tranche Update on Cytek Biosciences, Inc.'s Equity Buyback Plan announced on December 30, 2024. - marketscreener.com
Will Cytek Biosciences Inc. (8EQ) stock draw ESG focused funds2025 Fundamental Recap & AI Driven Stock Price Forecasts - Newser
Morgan Stanley Raises Price Target on Cytek Biosciences to $6 From $4, Keeps Equalweight Rating - marketscreener.com
Cytek Biosciences (CTKB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Published on: 2025-12-02 04:27:45 - Newser
What dividend safety score for Cytek Biosciences Inc. stockPortfolio Profit Report & Long-Term Safe Investment Ideas - moha.gov.vn
Check out these key findings about Cytek BioSciences Inc (CTKB) - Setenews
Bank of Montreal Can Boosts Stock Position in Cytek Biosciences, Inc. $CTKB - Defense World
Revenues Tell The Story For Cytek Biosciences, Inc. (NASDAQ:CTKB) As Its Stock Soars 43% - simplywall.st
Cytek Biosciences (NASDAQ:CTKB) Stock Price Up 7.2%Here's What Happened - MarketBeat
[Form 4] Cytek Biosciences, Inc. Insider Trading Activity - Stock Titan
Officer/Dir Yan Acquires 15,908 Of Cytek BioSciences Inc [CTKB] - TradingView
Why Cytek Biosciences Inc. stock could be next big winnerJuly 2025 Update & AI Driven Stock Reports - newser.com
Is Cytek Biosciences Inc. (8EQ) stock a good hedge against inflationJuly 2025 Summary & High Conviction Buy Zone Alerts - newser.com
Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth (CTKB) - Seeking Alpha
What technical charts say about Cytek Biosciences Inc. stockJuly 2025 Patterns & Reliable Momentum Entry Alerts - newser.com
Cytek Biosciences, Inc. (CTKB) Stock Forecasts - Yahoo! Finance Canada
Why Cytek Biosciences Inc. (8EQ) stock is favored by hedge fundsAnalyst Upgrade & Daily Oversold Stock Bounce Ideas - newser.com
Check Out Cytek BioSciences Inc (CTKB)’s Trade Data Rather Than the Analysts’ Views - Setenews
What technical models suggest about Cytek Biosciences Inc.’s comeback - newser.com
Can Cytek Biosciences Inc. stock maintain growth trajectoryTrade Performance Summary & Free Real-Time Market Sentiment Alerts - newser.com
Does TIME Recognition Signal a Turning Point for Cytek Biosciences' (CTKB) Competitive Edge in Innovation? - Yahoo Finance
Cytek Biosciences Inc (CTKB) 財務データ
収益
当期純利益
現金流量
EPS
Cytek Biosciences Inc (CTKB) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| McCombe William D. | Chief Financial Officer |
Jun 02 '25 |
Buy |
2.78 |
35,000 |
97,300 |
55,746 |
0.29%
0.10%
大文字化:
|
ボリューム (24 時間):